Status:

UNKNOWN

Percutaneous Coronary Intervention Versus Medical Treatment for Stable Angina Pectoris

Lead Sponsor:

Herlev and Gentofte Hospital

Conditions:

Coronary Heart Disease

Stable Angina

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Patients with ischemic heart disease and symptoms due to lack of oxygen to the heart on exertion (stable angina pectoris) are usually treated by either percutaneous coronary intervention (PCI) or opti...

Detailed Description

Ischemic heart disease (IHD) is a major cause of death and disability worldwide. Patients with ischemic heart disease and symptoms due to lack of oxygen to the heart on exertion (stable angina pectori...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Age 18-85 years
  • Patients with stable angina pectoris undergoing elective coronary angiography
  • Canadian Cardiovascular Society (CCS) class 2 or 3
  • Informed consent
  • Lesions in one or more coronary vessels with a diameter \>2.5 mm with FFR-values ≤0.80, and suitable for complete revascularization with PCI.
  • Exclusion criteria
  • Contraindication to PCI or dual antiplatelet therapy (DAPT)
  • Use of or indication for oral anticoagulants (OAC) or novel oral anticoagulants (NOAC)
  • Use of clopidogrel
  • Life expectancy of less than 2 years
  • Severe valvular disease
  • Severe comorbidity
  • Acute coronary event within the past 12 months
  • Left ventricular ejection fraction ≤35%.
  • Renal function with estimated glomerular filtration rate (eGFR) \<30 mL/min
  • Pregnant or nursing
  • Severe coronary artery disease (left main stenosis, 3-vessel disease, proximal left anterior descending stenosis, chronic total occlusion of major vessel)
  • Coronary disease where complete revascularization by PCI is considered difficult or impossible.

Exclusion

    Key Trial Info

    Start Date :

    June 15 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2022

    Estimated Enrollment :

    450 Patients enrolled

    Trial Details

    Trial ID

    NCT04496648

    Start Date

    June 15 2020

    End Date

    September 30 2022

    Last Update

    August 3 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Gentofte University Hospital

    Gentofte Municipality, Copenhagen, Denmark, 2900

    Percutaneous Coronary Intervention Versus Medical Treatment for Stable Angina Pectoris | DecenTrialz